ZHEJIANG CHENG YI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.3 CNY | +1.10% |
|
+10.37% | -19.96% |
| 04-25 | Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-07 | Cheng Yi Pharmaceutical Shareholder Boosts Stake in Firm | MT |
| Sales 2022 | 655M 90.47M 7.22B | Sales 2023 | 672M 92.77M 7.4B | Capitalization | 3.39B 469M 37.4B |
|---|---|---|---|---|---|
| Net income 2022 | 162M 22.38M 1.79B | Net income 2023 | 163M 22.52M 1.8B | EV / Sales 2022 | 5.32 x |
| Net Debt 2022 | 213M 29.46M 2.35B | Net Debt 2023 | 150M 20.68M 1.65B | EV / Sales 2023 | 5.28 x |
| P/E ratio 2022 |
20.3
x | P/E ratio 2023 |
20.7
x | Employees | 746 |
| Yield 2022 |
1.79% | Yield 2023 |
-
| Free-Float | 61.24% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.10% | ||
| 1 week | +10.37% | ||
| Current month | +4.67% | ||
| 1 month | +4.67% | ||
| 3 months | +0.85% | ||
| 6 months | -20.42% | ||
| Current year | -19.96% |
1 week
7.69
8.32
1 month
7.098.32
Current year
5.7810.62
1 year
5.7814.00
3 years
5.7814.71
5 years
5.7816.07
10 years
4.9216.86
| Managers | Title | Age | Since |
|---|---|---|---|
Chun Jian Zhao
CEO | Chief Executive Officer | 47 | 22/04/18 |
Sun Zhan Lü
DFI | Director of Finance/CFO | 45 | 11/03/16 |
Shi Sheng Li
BRD | Director/Board Member | 73 | 11/03/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tao Jin
BRD | Director/Board Member | 56 | 05/05/19 |
Yi Yi Yan
CHM | Chairman | 75 | 11/03/16 |
Bing Jun Ren
BRD | Director/Board Member | 58 | 11/03/16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 8.3 | +1.10% | 4,691,196 |
| 29/04/24 | 8.21 | +3.14% | 4,077,819 |
| 26/04/24 | 7.96 | -1.00% | 4,945,398 |
| 25/04/24 | 8.04 | +1.26% | 3,730,540 |
| 24/04/24 | 7.94 | +2.45% | 2,891,468 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes
Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and sales of bulk pharmaceutical chemicals of chemical medicine and preparations. The Companyâs products are on the spectrum from arthritis, dieresis to anti-virus and anti-tumor. The main products include bulk pharmaceutical chemicals, injections, capsules, intermediates and others.
Sector
Pharmaceuticals
Calendar
17/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -19.96% | 375M | |
| +29.96% | 699B | |
| +25.07% | 571B | |
| -4.72% | 364B | |
| +17.92% | 326B | |
| +3.57% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.80% | 154B |
- Stock Market
- Equities
- 603811 Stock
